Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

AGL

Angle (AGL)

Angle Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:AGL
FechaHoraFuenteTítuloSímboloCompañía
18/07/202404:08RNS Regulatory NewsAngle PLC Standard form for notification of major holdingsLSE:AGLAngle Plc
11/07/202409:07RNS Regulatory NewsAngle PLC Result of 2024 Annual General MeetingLSE:AGLAngle Plc
21/06/202404:52Alliance NewsAlliance NewsIN BRIEF: Angle says open offer raises proceeds of GBP500,000LSE:AGLAngle Plc
21/06/202401:00RNS Regulatory NewsAngle PLC Result of open offerLSE:AGLAngle Plc
18/06/202408:41RNS Regulatory NewsAngle PLC Posting of 2023 Annual Report & Notice of the AGMLSE:AGLAngle Plc
11/06/202401:00RNS Non-RegulatoryAngle PLC Parsortix and assays being showcased at EACR 2024LSE:AGLAngle Plc
06/06/202410:37RNS Regulatory NewsAngle PLC Publication of CircularLSE:AGLAngle Plc
05/06/202410:32Alliance NewsAlliance NewsEARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrowsLSE:AGLAngle Plc
05/06/202410:04RNS Regulatory NewsAngle PLC Results of placing and subscriptionLSE:AGLAngle Plc
05/06/202401:00RNS Regulatory NewsAngle PLC Proposed Placing, Subscription and Open OfferLSE:AGLAngle Plc
05/06/202401:00RNS Regulatory NewsAngle PLC Preliminary ResultsLSE:AGLAngle Plc
16/05/202414:09Alliance NewsAlliance NewsTRADING UPDATES: Bens Creek considers administration; Nexxen inks dealLSE:AGLAngle Plc
16/05/202401:00RNS Non-RegulatoryAngle PLC Study of ovarian cancer CTCs using ParsortixLSE:AGLAngle Plc
03/05/202406:17Alliance NewsAlliance NewsCORRECT: Angle shares up on assay development deal with AstraZenecaLSE:AGLAngle Plc
03/05/202405:50Alliance NewsAlliance NewsAngle shares up on assay development deal with AstraZenacaLSE:AGLAngle Plc
03/05/202401:00RNS Regulatory NewsAngle PLC New commercial agreement with large pharmaLSE:AGLAngle Plc
24/04/202404:32Alliance NewsAlliance NewsAngle shares jump on supplier agreement with with AstraZenecaLSE:AGLAngle Plc
24/04/202401:00RNS Regulatory NewsAngle PLC New commercial agreement with AstraZenecaLSE:AGLAngle Plc
22/04/202410:52Alliance NewsAlliance NewsIN BRIEF: Angle granted patents in US and Europe for Cellkeep slideLSE:AGLAngle Plc
22/04/202401:00RNS Regulatory NewsAngle PLC US and EU patents for innovative CellKeep™ slideLSE:AGLAngle Plc
08/04/202401:00RNS Non-RegulatoryAngle PLC Parsortix HER2 assay showcased at AACR 2024LSE:AGLAngle Plc
22/03/202402:00RNS Non-RegulatoryAngle PLC Parsortix at European breast cancer conferenceLSE:AGLAngle Plc
22/01/202412:03Alliance NewsAlliance NewsIN BRIEF: Angle highlights supportive data for DNA analysis toolLSE:AGLAngle Plc
22/01/202401:00RNS Non-RegulatoryAngle PLC Potential utility in precision oncologyLSE:AGLAngle Plc
04/01/202406:19Alliance NewsAlliance NewsAngle shares soar following "breakthrough" cancer diagnostics resultsLSE:AGLAngle Plc
04/01/202403:10Dow Jones NewsAngle PLC Shares Rise on Cancer Patient Blood Sample AnalysisLSE:AGLAngle Plc
04/01/202401:00UK RegulatoryAngle PLC Breakthrough clinical resultsLSE:AGLAngle Plc
02/01/202402:51Alliance NewsAlliance NewsIN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trialLSE:AGLAngle Plc
02/01/202401:00UK RegulatoryAngle PLC Contract announcement with Eisai Inc.LSE:AGLAngle Plc
11/12/202314:44Alliance NewsAlliance NewsTRADING UPDATES: Ondine Biomedical raises GBP2.9 million via placingLSE:AGLAngle Plc
 Showing the most relevant articles for your search:LSE:AGL